HK1210168A1 - Amine salt and crystals thereof - Google Patents
Amine salt and crystals thereofInfo
- Publication number
- HK1210168A1 HK1210168A1 HK15111010.6A HK15111010A HK1210168A1 HK 1210168 A1 HK1210168 A1 HK 1210168A1 HK 15111010 A HK15111010 A HK 15111010A HK 1210168 A1 HK1210168 A1 HK 1210168A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- crystals
- amine salt
- amine
- salt
- Prior art date
Links
- -1 Amine salt Chemical class 0.000 title 1
- 239000013078 crystal Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/16—Cyclodextrin; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012191080 | 2012-08-31 | ||
| PCT/JP2013/073442 WO2014034902A1 (fr) | 2012-08-31 | 2013-08-30 | Sel d'amine et cristaux associés |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1210168A1 true HK1210168A1 (en) | 2016-04-15 |
Family
ID=50183705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15111010.6A HK1210168A1 (en) | 2012-08-31 | 2015-11-09 | Amine salt and crystals thereof |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US9643940B2 (fr) |
| EP (1) | EP2891651B1 (fr) |
| JP (1) | JP6131956B2 (fr) |
| KR (1) | KR102119619B1 (fr) |
| CN (1) | CN104603117B (fr) |
| AU (1) | AU2013309872B2 (fr) |
| BR (1) | BR112015004459B1 (fr) |
| CA (1) | CA2882732C (fr) |
| DK (1) | DK2891651T3 (fr) |
| ES (1) | ES2623788T3 (fr) |
| HK (1) | HK1210168A1 (fr) |
| HU (1) | HUE032816T2 (fr) |
| IL (1) | IL237432B (fr) |
| MX (1) | MX344385B (fr) |
| MY (1) | MY177737A (fr) |
| NZ (1) | NZ705340A (fr) |
| PH (1) | PH12015500389A1 (fr) |
| PL (1) | PL2891651T3 (fr) |
| PT (1) | PT2891651T (fr) |
| RU (1) | RU2658823C2 (fr) |
| SG (1) | SG11201501451SA (fr) |
| TW (1) | TWI597274B (fr) |
| WO (1) | WO2014034902A1 (fr) |
| ZA (1) | ZA201501374B (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112022001817A2 (pt) * | 2019-08-04 | 2022-03-29 | Yeda Res & Dev | Métodos para a preparação de fluensulfono |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS503362B1 (fr) | 1970-06-10 | 1975-02-04 | ||
| JPS5231404B1 (fr) | 1971-04-28 | 1977-08-15 | ||
| FR2204408A1 (en) | 1972-10-27 | 1974-05-24 | Wirth Pierre | Phenylbutazone salts - sol in water and well tolerated |
| JPS57156460A (en) | 1981-03-20 | 1982-09-27 | Ono Pharmaceut Co Ltd | Stabilized composition of prostaglandin and prostaglandin mimic compound, and its preparation |
| JPS60197667A (ja) | 1984-03-19 | 1985-10-07 | Ono Pharmaceut Co Ltd | ６―ケト―プロスタグランジン類似化合物及びその製造方法 |
| DE69813571T2 (de) | 1997-02-10 | 2004-02-12 | Ono Pharmaceutical Co. Ltd. | 11,15-o-dialkylprostaglandin-e-derivate, verfahren zu ihrer herstellung und arzneimittel, die diese als aktiven inhaltsstoff enthalten |
| JPH11130678A (ja) | 1997-08-27 | 1999-05-18 | Kaken Pharmaceut Co Ltd | 神経圧迫による神経障害改善剤 |
| WO2003009872A1 (fr) | 2001-07-23 | 2003-02-06 | Ono Pharmaceutical Co., Ltd. | Medicaments contenant un agoniste de ep4 en tant que principe actif destines aux maladies associees a une perte de la masse osseuse |
| BR0308166A (pt) * | 2002-03-05 | 2005-01-18 | Ono Pharmaceutical Co | Compostos de derivados de 8-azaprostaglandina e drogas contendo os compostos como o ingrediente ativo |
| AU2002345285A1 (en) | 2002-07-11 | 2004-02-02 | Nokia Corporation | Method and device for automatically changing a digital content on a mobile device according to sensor data |
| JP4582456B2 (ja) | 2003-01-21 | 2010-11-17 | 小野薬品工業株式会社 | ８−アザプロスタグランジン誘導体およびその医薬用途 |
| WO2004089411A1 (fr) | 2003-04-03 | 2004-10-21 | Ono Pharmaceutical Co., Ltd. | Remede pour la stenose du canal vertebral |
| EP1707208A4 (fr) | 2003-12-05 | 2010-03-17 | Ono Pharmaceutical Co | Promoteur du flux sanguin dans les tissus de la queue de cheval |
| WO2005061492A1 (fr) | 2003-12-22 | 2005-07-07 | Ono Pharmaceutical Co., Ltd. | Composes heterocycliques azotes et medicaments dont ils sont le principe actif |
| JP4888775B2 (ja) * | 2004-08-10 | 2012-02-29 | 小野薬品工業株式会社 | Ｅｐ４アゴニストを含有してなる下部尿路系疾患の予防および／または治療剤 |
| US7858650B2 (en) | 2004-10-22 | 2010-12-28 | Ono Pharmaceutical Co., Ltd. | Medicinal composition for inhalation |
| BRPI0611079A2 (pt) | 2005-06-03 | 2010-08-03 | Ono Pharmaceutical Co | agentes para a regeneração e/ou proteção de nervos |
| WO2009148163A1 (fr) | 2008-06-06 | 2009-12-10 | 小野薬品工業株式会社 | Agent de contraction du muscle détrusor de la vessie et de relâchement du muscle sphincter urétral |
| RU2531350C2 (ru) | 2009-06-10 | 2014-10-20 | Оно Фармасьютикал Ко., Лтд. | Соединение, обладающее сокращающей детрузор активностью и релаксирующей уретральный сфинктер активностью |
-
2013
- 2013-08-30 MX MX2015002209A patent/MX344385B/es active IP Right Grant
- 2013-08-30 WO PCT/JP2013/073442 patent/WO2014034902A1/fr active Application Filing
- 2013-08-30 KR KR1020157004896A patent/KR102119619B1/ko active IP Right Grant
- 2013-08-30 AU AU2013309872A patent/AU2013309872B2/en not_active Ceased
- 2013-08-30 RU RU2015111568A patent/RU2658823C2/ru active
- 2013-08-30 DK DK13832178.1T patent/DK2891651T3/en active
- 2013-08-30 EP EP13832178.1A patent/EP2891651B1/fr active Active
- 2013-08-30 BR BR112015004459-0A patent/BR112015004459B1/pt not_active IP Right Cessation
- 2013-08-30 HU HUE13832178A patent/HUE032816T2/en unknown
- 2013-08-30 ES ES13832178.1T patent/ES2623788T3/es active Active
- 2013-08-30 NZ NZ705340A patent/NZ705340A/en not_active IP Right Cessation
- 2013-08-30 SG SG11201501451SA patent/SG11201501451SA/en unknown
- 2013-08-30 CA CA2882732A patent/CA2882732C/fr not_active Expired - Fee Related
- 2013-08-30 PL PL13832178T patent/PL2891651T3/pl unknown
- 2013-08-30 CN CN201380045485.XA patent/CN104603117B/zh active Active
- 2013-08-30 TW TW102131218A patent/TWI597274B/zh not_active IP Right Cessation
- 2013-08-30 JP JP2014533137A patent/JP6131956B2/ja active Active
- 2013-08-30 US US14/424,215 patent/US9643940B2/en active Active
- 2013-08-30 PT PT138321781T patent/PT2891651T/pt unknown
- 2013-08-30 MY MYPI2015700583A patent/MY177737A/en unknown
-
2015
- 2015-02-23 PH PH12015500389A patent/PH12015500389A1/en unknown
- 2015-02-26 IL IL237432A patent/IL237432B/en active IP Right Grant
- 2015-02-27 ZA ZA2015/01374A patent/ZA201501374B/en unknown
- 2015-11-09 HK HK15111010.6A patent/HK1210168A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273276A (en) | salt crystals | |
| HK1199840A1 (en) | Noribogaine salt ansolvates | |
| EP2915804A4 (fr) | Nouveau dérivé d'amine ou sel correspondant | |
| HK1201521A1 (en) | Heterocyclic compounds and methods for their use | |
| HK1201533A1 (en) | Heterocyclic compounds and methods for their use | |
| HK1201531A1 (en) | Heterocyclic compounds and methods for their use | |
| EP2886546A4 (fr) | Composé hétérocyclique et son utilisation | |
| HK1207643A1 (en) | Amides of 2-amino-4-arylthiazole compounds and their salts 2--4- | |
| EP2938607A4 (fr) | Sels et formes cristallines | |
| PL2840907T3 (pl) | Substytut soli | |
| EP2935227A4 (fr) | Diazole amides | |
| EP2902391A4 (fr) | Nouveau composé amine et son utilisation | |
| HK1215571A1 (zh) | 二鹽酸科比思特 | |
| EP2842937A4 (fr) | Composé amine et son utilisation à des fins médicales | |
| EP2813508A4 (fr) | Composé hétérocyclique et application associée | |
| HK1210168A1 (en) | Amine salt and crystals thereof | |
| GB201220447D0 (en) | Releasable fastener | |
| GB201219293D0 (en) | Pyroelectric crystals |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20220826 |